About Insulin Sliding Scales

An insulin sliding scale is a tool used by healthcare professionals to determine a patient's dose of rapid-acting or short-acting insulin based on their current blood glucose level. The scale provides a pre-set dosage to correct for hyperglycemia, typically administered before meals and at bedtime. This Insulin Sliding Scale Generator calculator helps clinicians create individualized correctional and nutritional insulin dosing protocols based on key patient parameters.

Outputs of the Generator

The tool generates two primary components for a comprehensive insulin regimen:

• Correctional Insulin Scale: This is a table that matches blood glucose (BG) ranges with a specific number of insulin units. Its purpose is to correct high blood sugar readings back to a target range. The scale is built using a Correction Factor (CF), also known as an Insulin Sensitivity Factor (ISF), which defines how much 1 unit of insulin will lower the patient's blood glucose.
• Nutritional Dosing Guide: This table provides recommended insulin doses to cover the carbohydrates consumed in a meal. It is based on the Insulin-to-Carb Ratio (ICR), which specifies how many grams of carbohydrates are "covered" by 1 unit of insulin.

How to Use This Information

A clinician uses patient-specific data to generate a scale. Key inputs include:

• Total Daily Dose (TDD): The patient's total insulin usage over 24 hours. This is the preferred method for calculating CF and ICR using standard formulas (e.g., the "1800 Rule" for rapid-acting insulin).
• Target Blood Glucose: The desired BG range for the patient (e.g., 140-180 mg/dL for many hospitalized patients).
• Correction Factor (CF) & Insulin-to-Carb Ratio (ICR): If the TDD is unknown, these values can be entered directly based on clinical assessment and prior experience with the patient.
• Insulin Type: The choice between rapid-acting (e.g., Lispro, Aspart) and short-acting (Regular) insulin affects the calculation formulas and administration timing.

Dosing Overview

Sliding scale insulin (SSI) is most effective when used as part of a complete basal-bolus regimen, which includes a long-acting (basal) insulin for background coverage and rapid/short-acting (bolus) insulin for meals and corrections.

• Correction Doses: Administered when a pre-meal or bedtime blood glucose reading is above the target range.
• Nutritional Doses: Administered before a meal to cover anticipated carbohydrate intake. The correctional and nutritional doses are often combined into a single injection.
• Administration Timing: Rapid-acting insulins should be given 0–15 minutes before a meal, while short-acting (Regular) insulin is typically given 30 minutes prior.

Switching Insulin Regimens

When transitioning a patient to a sliding scale as part of a basal-bolus regimen, careful calculation is required. If switching from a different insulin type (e.g., premixed or NPH/Regular), the Total Daily Dose must be accurately calculated to serve as the basis for the new regimen. Often, a 20-25% dose reduction is considered to prevent hypoglycemia during the transition, with subsequent adjustments based on blood glucose monitoring.

Missed Dose Protocol

If a pre-meal (bolus) dose of insulin is missed, the patient should not take the dose late if the meal has already been consumed, as this can lead to hypoglycemia. They should monitor their blood glucose and follow the correctional scale at the next scheduled check. The patient's healthcare provider should be consulted for specific guidance, especially if doses are frequently missed.

Safety Alerts

Frequently Asked Questions

What is the difference between the 1800 Rule and the 1500 Rule?

These are formulas to estimate the Correction Factor (CF). The 1800 Rule is used for rapid-acting insulins (1800 / TDD = CF), while the 1500 Rule is used for short-acting (Regular) insulin (1500 / TDD = CF). The result indicates how many points (in mg/dL) 1 unit of insulin will lower blood glucose.

Why does the calculator need my Total Daily Dose (TDD)?

TDD is the most reliable clinical input for calculating a personalized Correction Factor and Insulin-to-Carb Ratio. It bases the new scale on the patient's established insulin requirements, leading to a more accurate and safer starting point.

What is a Correction Factor (CF) or Insulin Sensitivity Factor (ISF)?

CF (or ISF) represents how sensitive a patient is to insulin. A CF of 30 means that one unit of insulin is expected to lower the patient's blood glucose by 30 mg/dL.

What is an Insulin-to-Carb Ratio (ICR)?

ICR is used for nutritional (mealtime) insulin dosing. An ICR of 10 means that one unit of insulin will cover 10 grams of carbohydrates consumed.

Can I use this scale for long-acting insulins like Lantus or Basaglar?

No. Sliding scales are designed exclusively for rapid-acting (e.g., Lispro, Aspart, Glulisine) or short-acting (Regular) insulins used to correct high blood sugar and cover meals. Long-acting (basal) insulins have a fixed dose and are not used in a sliding scale.

What should I do if my blood sugar is below the target range?

If your blood glucose is below the target range, especially below 70 mg/dL (3.9 mmol/L), you should not take correction insulin. You must initiate your prescribed hypoglycemia treatment protocol (e.g., the "rule of 15") and contact your healthcare provider.

Why is the nutritional guide based on carbohydrate increments?

The guide provides quick-reference doses for common carbohydrate amounts (e.g., 15g, 30g, 45g) to simplify mealtime dosing without requiring precise calculation for every meal, which is useful in hospital settings or for patient education.

Is a sliding scale alone enough to manage diabetes?

For most patients with Type 1 diabetes and many with Type 2, a sliding scale alone is insufficient for optimal glycemic control. It is a reactive approach that only addresses existing hyperglycemia. It should be part of a proactive basal-bolus regimen that includes long-acting insulin.

References

1. American Diabetes Association. 15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2023. Diabetes Care. 2023;46(Supplement_1):S247-S258. doi:10.2337/dc23-S015
2. Umpierrez GE, Palacio A, Smiley D. Sliding scale insulin use in the hospital: understanding the challenges and prescribing for success. Biomed J. 2017;40(5):265-271. doi:10.1016/j.bj.2017.07.007
3. National Institute for Health and Care Excellence (NICE). Type 1 diabetes in adults: diagnosis and management. NICE guideline [NG17]. Published: 26 August 2015. Last updated: 29 June 2022. www.nice.org.uk/guidance/ng17
4. U.S. Food & Drug Administration (FDA). Drugs@FDA: FDA-Approved Drugs. Includes access to prescribing information for various insulin products. www.accessdata.fda.gov/scripts/cder/daf/